Clinical research on tDCS for depression
The Flow brain stimulation treatment is based on decades of clinical research with the most recent meta-analyses showing that tDCS has similar efficacy to other treatments but with fewer side effects.
Across 20+ randomized controlled trials, tDCS has been shown to be superior to placebo/sham and no serious adverse events have been observed. Hence, tDCS provides an alternative to medication that is effective, safe and accessible
Clinical research on behaviour therapy and lifestyle factors depression
The Flow therapy app is based on a hundred years of psychological research, showing that exercise, sleep, diet and meditation all have an impact on reducing depressive symptoms when incorporated into a regular routine.
The Flow treatment has proven effective, both by research trials conducted by third parties and by internal analysis conducted by Flow Neuroscience.
The Flow treatment has been shown in multiple clinical trials to have a positive impact on depression and to reduce depressive symptoms within 3 weeks.
Internal analysis shows 81% of Flow users experiencing an increase in focus, mood and optimism with 30% overcoming depression completely
If you are based in England, Wales or Texas and have moderate to severe depression you might be eligible to join a clinical trial using the Flow tDCS headset and contribute to improving the future of depression treatment.